Associated Press - December 15, 2005

The Centers for Disease Control and Prevention said Thursday that the test -- called the QuantiFERON-TB Gold -- is less likely to yield false positive readings and more convenient for patients.

"This is one of the first TB advancements made since the discovery of antibiotics. ... This is a huge deal," said Jennifer Grinsdale, an epidemiologist with the San Francisco Department of Public Health.

With the skin test, a health care worker injects a small amount of protein-bearing testing fluid -- called tuberculin -- just under the skin on the underside of the forearm. After two or three days, the patient must return so that the health care worker can assess the swelling and decide if the test is positive or not.

With the QFT Gold test, the patient must come in only once, to have some blood drawn. The patient is then notified when the results become available, which can be as soon as the next day.

It also seems to address gripes health officials have had with the skin test.

"I like to refer to the tuberculin skin test as the test we love to hate," said Dr. Kenneth Castro, director of the CDC's Division of Tuberculosis Elimination.

Certain non-tuberculosis bacteria can cause the skin test to yield a false-positive. People who have received a certain type of TB vaccine used in other countries are also prone to have false positives. People with AIDS or other immune deficiency conditions sometimes receive false negatives.

The new test is believed to be better at avoiding the false positives, Castro said. However, more study is needed, especially in use of the test on children and in people with compromised immune systems, CDC officials said.

"We're saying this can be used instead of the tuberculin test. But we're not going as far as saying it should replace it," Castro said.

The QFT Gold test is made by an Australian company, Cellestis Limited. The U.S. Food and Drug Administration approved the product in May.

An earlier version of the QFT test was recommended by the CDC, but with restrictions on which types of cases it should be used in.

It was not considered much more accurate than the skin test and it was not well received by most local health departments, said Dr. Neil Schluger, an associate professor of medicine and public health at Columbia University who chaired a CDC advisory committee that reviewed the QFT Gold test.

Each QFT Gold test kit costs about $15, and an additional $10 or so to administer. The skin test equipment is less expensive, but labor costs to get a result brings it to about the same price, said Dr. Masae Kawamura, director of the TB control section at the San Francisco health department.

The San Francisco health department started using the QFT Gold test in February, and now does most of its TB testing that way. It has led to large drops in positive readings, probably because the skin test was yielding false positives, Kawamura said. She said more accurate diagnoses could mean a reduction in health-care costs.

"It really is a paradigm shift for those of us in TB control," Kawamura said.

051215
AP051225

Copyright © 2005 - Associated Press. Reproduction of this article (other than one copy for personal reference) must be cleared through the AP Permissions Desk.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.

Always watch for outdated information. This article first appeared in 2005. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2005. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .